Table 1 |
|
|
Patient and tophus characteristics at the time of surgerya |
|
|
Patient characteristics (n = 8) |
|
|
No. (%) male |
7 (88) |
|
Age, median (range) years |
46 (31 to 67) |
|
Duration of gout, median (range) years |
12 (4 to 30) |
|
No. (%) prescribed allopurinol |
6 (75) |
|
No. (%) prescribed colchicine |
7 (87.5) |
|
No. (%) prescribed nonsteroidal anti-inflammatory drugs |
2 (25) |
|
Serum urate, median (range) mg/dl |
6.6 (5 to 9.8) |
|
CRP, median (range) mg/dl |
0.84 (0.2 to 4.3) |
|
Tophus characteristics (n = 14) |
|
|
Duration of tophus, median (range) years |
5 (1.5 to 7) |
|
Location of tophus |
|
|
First MTP joint, No. (%) |
7 (50) |
|
Ankle joint, No. (%) |
4 (29) |
|
Elbow joint, No. (%) |
2 (14) |
|
Hand PIP joint, No. (%) |
1 (7) |
|
Indication for surgery |
|
|
Mechanical problem, No. (%) |
10 (71) |
|
Pain control, No. (%) |
4 (28) |
|
Sepsis control (infected/ulcerated tophi), No. (%) |
0 (0) |
|
|
|
|
CRP, C-reactive protein; MTP, metatarsophalangeal; No., number; PIP, proximal interphalangeal. aData are presented as medians and ranges or percentages. |
|
|
Lee et al. Arthritis Research & Therapy 2011 13:R164 doi:10.1186/ar3483 |
|
